Clinical Trial Update: Reversal of Atrial Substrate to Prevent Atrial [NA]

View source ↗

Summary

An update on a clinical trial evaluating reversal of atrial substrate to prevent atrial fibrillation. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Atrial Fibrillation | NA | Status: ACTIVE_NOT_RECRUITING